Zolmax Headlands Technologies LLC boosted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 96.3% in the 2nd quarter, according to its most recent disclosure with the Securities and...\n more…
Zolmax Victory Capital Management Inc. lifted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 42.7% in the second quarter, HoldingsChannel.com reports. The fund owned...\n more…
Ticker Report Needham Company LLC reaffirmed their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ - Free Report) in a report published on Tuesday, Benzinga reports. Needham Company LLC...\n more…
Ticker Report Jazz Pharmaceuticals (NASDAQ:JAZZ - Get Free Report)s stock had its "overweight" rating reiterated by investment analysts at Cantor Fitzgerald in a research note issued on Monday, Benzinga...\n more…